BSE filing, NSE: SANDUMA. Summary written from the filing by ALFA Finder's alert engine.
Sandur Manganese & Iron Ores Ltd: key numbers
- Share price
- ₹164.20
- Market cap
- ₹7,982 Cr
- Revenue (annual)
- ₹5,088 Cr
- Net profit (annual)
- ₹656.6 Cr
- P/E (TTM)
- 11.1×Sector 16.8×
- Promoter holding
- 74.22%+0.00% QoQ
- FII holding
- 1.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sandur Manganese & Iron Ores Ltd
All →Sandur Manganese & Iron Ores Q2 FY27 Results: Net Profit ₹261.2 Cr, Up 88.0% YoY
Sandur Manganese & Iron Ores Ltd reported revenue from operations of ₹1,506 Cr (+22.2% YoY) and net profit of ₹261.2 Cr (+88.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹261.2 Cr · +88.0% YoY
Sandur Manganese & Iron Ores Board Meeting Date
Sandur Manganese & Iron Ores will hold a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window is closed from 1 October 2026 until 48 hours after the meeting.
Sandur Manganese & Iron Ores Capacity Expansion
SMIORE's subsidiary Royal Sandur MedTech leased 6.2 acres at AP MedTech Zone, Visakhapatnam for a medical devices manufacturing unit. This marks the company's entry into the medical devices segment.
- Execution
- 33-year lease tenure
- land for medical devices manufacturing unit
- 6.2 acres
Sandur Manganese & Iron Ores Other Announcement
Sandur Manganese & Iron Ores Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, as required by SEBI regulations.
Sandur Manganese & Iron Ores Merger & Restructuring Worth ₹1 Cr
The Sandur Manganese & Iron Ores Ltd incorporated a new wholly owned subsidiary, Royal Sandur MedTech Private Limited, for medical devices and consumables manufacturing.
- Value
- ₹1.00 Cr
Sandur Manganese & Iron Ores Merger & Restructuring Worth ₹1 Cr
Sandur Manganese & Iron Ores approved the incorporation of a wholly-owned subsidiary, 'Royal Sandur MedTech Private Limited', with a capital investment of ₹1 Crore.
- Value
- ₹1.00 Cr
Other management change announcements
All →Dhampure Specialty Sugars Management Change
Dhampure Specialty Sugars appointed Dr. Ravinder Nath Batta as Additional Independent Director, subject to shareholder approval. The five-year term carries no disclosed financial impact.
Deepak Chemtex Management Change
Deepak Chemtex appointed Mr. Gourav Darak as Company Secretary and Compliance Officer, effective 3 November 2026. He is an ICSI associate member with about 10 years' experience.
The Indian Card Clothing Company Management Change
Indian Card Clothing appointed Manasi M. Nisal as Chief Financial Officer, effective 4 November 2026. She is a Chartered Accountant with over 25 years of finance leadership.
Konndor Industries Management Change
Konndor Industries appointed Ms. Pooja Arvind Goyal as a Director at its 3 November 2026 board meeting. The appointment carries no disclosed financial value.
All Time Plastics Management Change
All Time Plastics disclosed that Girish Shete, Vice President – Operations and senior management, resigned with last working day 30 November 2026. The resignation was accepted and cited personal and family reasons.
DIC India Management Change
DIC India reported two independent directors, Prabal Kumar Sarkar and Pritha Dutt, resigning effective November 5, 2026. The company confirmed no material reasons beyond their letters.